Understanding Acetaminophen Metabolism and Toxicity
At therapeutic doses, acetaminophen undergoes conjugation (95%) and oxidation (5%) in the liver. The minor oxidative pathway generates N-acetyl-p-benzoquinoneimine (NAPQI), a reactive metabolite normally neutralised by hepatic glutathione. In overdose, glutathione becomes depleted, allowing NAPQI to accumulate and cause hepatocyte necrosis.
Toxicity risk depends on three factors:
- Ingested dose — amounts exceeding 140 mg/kg carry significant risk
- Time since ingestion — metabolism continues, shifting risk categories over hours
- Serum concentration — plotted against the nomogram to determine treatment threshold
The treatment line sits at 0.75 (or 3/4) of the toxic threshold. If a patient's serum level falls above this line at the measured time point, NAC therapy is indicated to replenish glutathione and prevent fulminant hepatic failure.
NAC Dosing by Route of Administration
The calculator computes loading and maintenance doses based on body weight and whether NAC is given orally or intravenously. Intravenous administration achieves higher serum concentrations more rapidly, while oral dosing requires larger volumes but may be suitable in alert patients.
Intravenous route:
Loading dose [mg] = weight [kg] × 150 mg
Second dose [mg] = weight [kg] × 50 mg
Third dose [mg] = weight [kg] × 100 mg
Oral route:
First dose [mg] = weight [kg] × 140 mg
Subsequent doses [mg] = weight [kg] × 70 mg
weight— Patient body weight in kilograms; critical for all dose calculationsroute— Method of NAC delivery: intravenous (IV) or per os (oral)loadDiluent— Volume of diluent (typically 5% dextrose or saline) mixed with the loading dose for IV administrationsecDiluent— Diluent volume for the second IV infusionthirdDiluent— Diluent volume for the third IV infusion
The Rumack-Matthew Nomogram and Risk Stratification
The nomogram plots serum acetaminophen concentration (y-axis, logarithmic scale) against hours post-ingestion (x-axis). Two key lines define clinical zones:
- Toxic line — the upper boundary above which hepatotoxicity is probable without treatment
- Treatment line — 75% of the toxic line; levels here warrant NAC initiation to prevent liver damage
Timing of the serum draw matters considerably. Absorption occurs over 30–120 minutes after oral ingestion; drawing levels before peak concentration can underestimate actual overdose. The nomogram assumes a single acute ingestion; repeated doses or modified-release formulations complicate interpretation.
Modern practice uses the nomogram alongside clinical judgment. Patients ingesting more than 140 mg/kg should receive NAC empirically if they present within 24 hours, even before serum results return. Delays in treatment significantly worsen outcomes.
Clinical Phases of Acetaminophen Poisoning
Without prompt antidote therapy, four distinct phases emerge:
- Phase 1 (0–24 hours): Nausea, vomiting, anorexia, and abdominal discomfort. Patient may appear well, obscuring severity.
- Phase 2 (24–72 hours): Apparent clinical improvement but rising liver enzymes. Jaundice, right upper quadrant pain, and elevated transaminases signal hepatic injury.
- Phase 3 (72–96 hours): Peak liver dysfunction. Coagulopathy, encephalopathy, hypoglycaemia, and multi-organ failure may occur.
- Phase 4 (≥4 days): Either recovery with gradual normalisation of liver function or progression to fulminant failure and death.
NAC interrupts this cascade by restoring glutathione levels and stabilising hepatocytes, particularly if given within 8–10 hours of ingestion.
Critical Considerations When Dosing NAC
Several factors affect NAC efficacy and safety; clinicians must account for them during treatment.
- Time is the strongest predictor of success — NAC given within 8 hours of ingestion prevents virtually all liver toxicity. Between 8–24 hours, efficacy declines but treatment remains worthwhile. Beyond 24 hours, NAC may still reduce mortality but hepatic necrosis is harder to prevent. Never delay transport to hospital awaiting serum results if a large overdose is suspected.
- Account for delayed absorption with modified-release formulations — Some acetaminophen products release drug slowly over hours. A serum level drawn at 4 hours may still reflect rising concentrations, placing the patient in a higher-risk category than the nomogram suggests. If modified-release ingestion is suspected, obtain repeat serum levels or extend NAC therapy empirically.
- Oral NAC tastes unpleasant and vomiting occurs frequently — The oral solution smells and tastes of rotten eggs (due to sulphur content). Nausea from the overdose itself, combined with NAC's odour, makes administration challenging. Diluting in cola or juice, using antiemetics, and slow infusion improve tolerance. IV administration avoids this problem but requires hospital access.
- Monitor for NAC-related anaphylaxis — Rapid IV infusion can trigger anaphylactoid reactions: flushing, bronchospasm, hypotension, and angioedema. Slow the loading dose over 1 hour, pretreat with antihistamines and steroids if high-risk, and have resuscitation equipment available. Anaphylaxis is not a contraindication to continuing treatment; it mandates slower infusion rates.